Cardiac Intervention Set (CiSet)
When treating patients with high-risk PCI, the physician should take into account a 7 - 10% risk of acute hemodynamic instability; this almost always leads to the need for urgent circulatory support. Cardiac assist devices can be used to regain stability and to support the patient as quickly and effectively as possible.
- Rising numbers of cardiac interventions are occurring, especially in older and sicker patients   
- Increasingly complex cardiac interventions occur after the introduction of new stent variations (e.g. drug eluting or dissolving stents) and evolving technologies (e.g. minimally invasive valve-replacement) 
- Increased need for, and acceptance of circulatory support during high-risk PCI    or valve replacement.
Benefits at a glance
The small and lightweight heart-lung support system.
Designed for veno-venous and veno-arterial vessel access. These cannulae provide easy and reliable connection of peripheral vessels to an extracorporeal circuit
Avalon Elite Bi-Caval Dual Lumen Catheter
The world’s first single site, kink resistant, veno-venous device designed to enable optimal extracorporeal life support
HLS Set Advanced
The HLS Set Advanced provides complete monitoring and is specially developed for veno-venous or veno-arterial extracorporeal support for up to 30 days (CE region) continuous use.
SPRINTER CART XL
A workstation for extracorporeal support devices and applications in the operating room and intensive care unit, as well as for patient transport
Briguori C et al. Elective versus provisional intra-aortic balloon pumping in ULMS.
Am. Heart J. 2006; 152 (3): 565-572
Vainer J et al. Elective high-risk percutaneous coronary interventions supported by extracorporeal life support.
Am. J. Cardiol. 2007; 99 (6): 771-3
Anastasiadis K et al. Successful high-risk percutaneous coronary intervention with the use of minimal extracorporeal cirulation system.
Catheter Cardiovasc Interv. 2012; 80 (5): 845–9
Tsao et al. Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock.
J. Crit. Care. 2012; 27 (5): 530.e1-530.e11
Dardas P et al. ECMO as a bridge to high-risk rotablation of heavily calcified coronary arteries.
Herz. 2012; 37 (2): 225-30
Bagai J et al. Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest.
J. Invasive Cardiol. 2011; 23 (4): 141-7
Webb DP et al. Novel multi-functional life support system.
J. Extra Corpor. Technol. 2010; 42 (3): 232-4